Related Experiment Video
Updated: Aug 7, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
[Course and prognosis of levels of CD4 molecules in HIV-infected patients]
J Pinilla Moraza1, F Antón Botella, P Labarga Echeverría
1Servicio de Medicina Interna, Complejo Hospitalario San Millán-San Pedro, Logroño, La Rioja.
Insights
In HIV patients, both CD4 lymphocyte counts and CD4 molecule concentration decrease over time. CD4 molecule concentration is a valuable prognostic marker for disease progression, similar to CD4 lymphocyte counts.
Area of Science:
- Immunology
- Virology
- Clinical Medicine
Background:
- Human Immunodeficiency Virus (HIV) infection leads to a decline in immune function.
- CD4+ T lymphocytes are critical for immune response and are a primary target of HIV.
- Monitoring CD4 cell counts is standard for assessing HIV disease progression.
Purpose of the Study:
- To measure CD4 molecule concentration on lymphocyte surfaces in HIV-infected patients.
- To track the evolution of CD4 molecule concentration over one year.
- To evaluate CD4 molecule concentration as a prognostic marker for HIV disease progression compared to CD4 lymphocyte counts.
Main Methods:
- Collected clinical and analytical data from 107 HIV patients, with 64 completing one year of follow-up.
- Measured CD4 molecule concentration using immunoassay and CD4 cell counts.
- Classified patients based on initial CD4 counts and clinical status (asymptomatic, AIDS-related complex, AIDS).
Main Results:
- A significant decrease in T4 lymphocytes and CD4 molecules was observed in the overall population and specific subgroups.
- Progressors showed significantly lower mean T4 lymphocyte counts (140/mm3) and CD4 molecule concentrations (3.87 pmol/l) compared to non-progressors.
- In asymptomatic patients, only the decrease in CD4 molecule concentration reached statistical significance.
Conclusions:
- Both CD4 lymphocyte count and CD4 molecule concentration decline over time in HIV-infected individuals.
- CD4 molecule concentration serves as a prognostic marker for HIV disease progression, comparable in value to CD4 lymphocyte counts.
- The measurement of CD4 molecule concentration offers a similar prognostic utility to CD4 lymphocyte enumeration in HIV management.
Objective:
To measure CD4 molecule concentration on lymphocyte surface. And observe its evolution during one year, in HIV infected patients. To assess the importance of this measure as a prognostic marker for disease progression, compared with the total number of CD4 lymphocytes.
Methods:
Clinical and analytical data from 107 patients were collected; 64 fulfilled a one-year follow-up. 45 were initially asymptomatic (ASN), 13 had AIDS-related complex (CRS) and 6 had AIDS. CD4 cell count was higher than 500 in 16, between 500 and 200 in 20, and lower than 200 in 28. CD4 molecule concentration in lymphocytes was measured with immunoassay capcellia CD4/CD8 (Pasteur Institute, Paris). During one year 12 patients progressed cunically.
Results:
There was significant decrease of T4 lymphocytes in the following groups whole population, CRS, more than 500 (initially). There were significant decreases of CD4 molecules in the following groups: whole population, ASN, CRS, more than 500 (initially), between 500 and 200 (initially), the mean number of T4 lymphocytes was 140/mm3 in progressors versus 358 in non-progressors (p < 0.05). Initial CD4 molecule concentration was 3.87 pmol/l in progressors versus 11.50 pmol/l in non-progressors (p < 0.05).
Conclusions:
Both total number of T4 lymphocytes and CD4 molecule concentration decrease with time. However, in asymptomatic patients only CD4 molecule decrease reaches statistical signification. Both T4 lymphocyte number and CD4 molecule concentration were lower in progressors. Measurement of CD4 molecule concentration is a parameter of similar value with respect to T4 lymphocyte count, and with similar value as progression marker.
Related Concept Videos
Retrovirus Life Cycles
Cryptococcal Meningitis

